The DCB currently remains an investigational device and is not available for sale in the US. "Airiver Medical receives FDA ...
Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI ...
Amazon S3 on MSN
Breakthrough AI spots cancer risk with high accuracy
Scientists may have just taken a huge step toward predicting one of cancer’s most dangerous behaviors — metastasis. In this video, we explore a groundbreaking artificial intelligence model developed ...
Mosaic expects the collaboration with the FDA will help address diagnostic capacity constraints in the US healthcare system.
Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...
Japan has approved the world’s first stem cell therapy for Parkinson’s disease, offering new hope for millions globally. The treatment uses induced pluripotent stem (iPS) cells to replace damaged ...
The creation of this new approach to stopping bleeding has unparalleled potential if moved forward in the medical industry, and could save countless lives in the process. As SciTechDaily first ...
Medical Device Network on MSN
FDA grants breakthrough designation to PathAI for pathology solution
The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.
Conventional wearable ultrasound sensors have been limited by low power output and poor structural stability, making them unsuitable for high-resolution imaging or therapeutic applications. A KAIST ...
The Company looks to build on its recent momentum - receiving FDA approval to expand its pivotal clinical trial into the second and final stage "This implant has truly changed my life," Craig Eggert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results